Professional
Added to YB: 2024-08-14
Pitch date: 2024-06-30
BAX [bullish]
Baxter International Inc.
-41.06%
current return
Author Info
No bio for this author
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$9.3B
Pitch Price
$32.49
Price Target
N/A
Dividend
0.22%
EV/EBITDA
7.79
P/E
-26.24
EV/Sales
1.57
Sector
Health Care Equipment and Supplies
Category
value
Artisan Value Income Fund Portfolio Holding: Baxter International Inc.
BAX: Beat Q2, raised guidance. Shares down on weakness in Hillrom biz. Selling non-core ops (BioPharma, kidney) to raise cash, simplify. Trades cheap on sum-of-parts valuation. Pessimism high due to past growth challenges. Upside potential as co. refocuses on profitable growth in core areas: renal, medication delivery, surgery, nutrition, pharma, acute therapies.
Read full article (1 min)